Catch These Diabetes Manifestation Coding Clues
Identifying the specific manifestation shows the severity or progression of the diabetes and shows the patient may require more complex care. The secondary diagnosis may help justify a higher-level E/M code (such as 99214, Office or other outpatient visit for the evaluation and management of an established patient) because it indicates the internist is dealing with diabetes involving a specific manifestation.
Question: An internist’s documentation states, “DM complicated by neuropathy.” Should I assign 250.60?
Illinois Subscriber
Answer: If the patient has type II diabetes--or an unspecified type--and the internist did not state that the patient’s diabetes was uncontrolled, you should classify diabetes mellitus (DM) with neurological manifestations as 250.60 (Diabetes with neurological manifestations; type II or unspecified type, not stated as uncontrolled).
Next step: Diabetes manifestation codes 250.4x-250.7x require an additional code to identify the diabetic manifestation, according to CPT’s notes following each four-digit code entry. Therefore, your ICD-9 coding is incomplete without the neuropathy code. Check the chart notes for the patient’s specific diabetic neuropathic manifestation:
• mononeuropathy (354.0-355.9)
• periphereal autonomic neuropathy (337.1)
• polyneuropathy (357.2).
Red flag: Don’t routinely code the patient’s manifestation. You should list only the complications that the internist addresses at that visit.
Example: An internist treats a type II patient with vision problems for a hypoglycemic incident. You should link 250.82 (Diabetes with other specified manifestations; type II or unspecified type, uncontrolled) rather than 250.52 (Diabetes with ophthalmic manifestations ...) to the appropriate office visit code (99201-99215, New or established patient office visit), because the reason for the visit was hypoglycemia. Also code any associated ulceration (707.10-707.9) or diabetic bone changes (731.8). If a drug caused the incident, use an E code to identify the drug.